Vir Biotechnology, Inc. Shares Issued
Vir Biotechnology, Inc. (VIR) had Shares Issued of 169.19 million shares as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-05
- 2026-06-30: Common Stock, Shares, Issued 169.19M shares.
- 2026-03-31: Common Stock, Shares, Issued 161.23M shares.
- 2025-12-31: Common Stock, Shares, Issued 139.47M shares.
- 2025-09-30: Common Stock, Shares, Issued 139.02M shares.
| Period end | Common Stock, Shares, Issued |
|---|---|
| 2026-06-30 | 169.19M shares 10-Q · filed 2026-08-05 |
| 2026-03-31 | 161.23M shares 10-Q · filed 2026-05-07 |
| 2025-12-31 | 139.47M shares 10-Q · filed 2026-08-05 |
| 2025-09-30 | 139.02M shares 10-Q · filed 2025-11-05 |
| 2025-06-30 | 138.89M shares 10-Q · filed 2025-08-06 |
| 2025-03-31 | 138.06M shares 10-Q · filed 2025-05-08 |
| 2024-12-31 | 136.96M shares 10-K · filed 2026-02-23 |
| 2024-09-30 | 136.71M shares 10-Q · filed 2024-11-04 |
| 2024-06-30 | 136.59M shares 10-Q · filed 2024-08-01 |
| 2024-03-31 | 135.84M shares 10-Q · filed 2024-05-03 |
| 2023-12-31 | 134.78M shares 10-K · filed 2025-02-27 |
| 2023-09-30 | 134.50M shares 10-Q · filed 2023-11-03 |
| 2023-06-30 | 134.23M shares 10-Q · filed 2023-08-04 |
| 2023-03-31 | 133.93M shares 10-Q · filed 2023-05-08 |
| 2022-12-31 | 133.24M shares 10-K · filed 2024-02-26 |
| 2022-09-30 | 133.03M shares 10-Q · filed 2022-11-03 |
| 2022-06-30 | 132.60M shares 10-Q · filed 2022-08-09 |
| 2022-03-31 | 132.35M shares 10-Q · filed 2022-05-05 |
| 2021-12-31 | 131.16M shares 10-K · filed 2023-02-28 |
| 2021-09-30 | 130.83M shares 10-Q · filed 2021-11-04 |
| 2021-06-30 | 130.48M shares 10-Q · filed 2021-08-05 |
| 2021-03-31 | 129.89M shares 10-Q · filed 2021-05-06 |
| 2020-12-31 | 127.42M shares 10-K · filed 2022-02-28 |
| 2020-09-30 | 126.99M shares 10-Q · filed 2020-11-10 |
| 2020-06-30 | 117.73M shares 10-Q · filed 2020-08-11 |
| 2020-03-31 | 108.35M shares 10-Q · filed 2020-05-12 |
| 2019-12-31 | 107.65M shares 10-K · filed 2021-02-25 |
| 2019-09-30 | 11.73M shares 10-Q · filed 2019-11-19 |
| 2018-12-31 | 8.86M shares 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |